Aspen Aerogels (NYSE:ASPN) Coverage Initiated at TD Cowen

TD Cowen assumed coverage on shares of Aspen Aerogels (NYSE:ASPN - Free Report) in a research report sent to investors on Friday morning. The firm issued a buy rating and a $11.00 target price on the construction company's stock.

Other equities analysts have also recently issued research reports about the company. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Craig Hallum decreased their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday, February 14th. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Finally, Roth Mkm reduced their price target on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average target price of $19.11.

Remove Ads

Aspen Aerogels Stock Up 1.4 %

ASPN stock traded up $0.11 during trading hours on Friday, reaching $7.91. 1,776,389 shares of the stock were exchanged, compared to its average volume of 2,118,359. The company has a market cap of $648.76 million, a price-to-earnings ratio of 49.42 and a beta of 2.28. The firm's 50-day moving average is $10.70 and its 200-day moving average is $16.85. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 12 month low of $6.70 and a 12 month high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, equities research analysts expect that Aspen Aerogels will post 0.17 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Toronto Dominion Bank acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at approximately $266,000. AWM Investment Company Inc. increased its stake in Aspen Aerogels by 2.9% in the fourth quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company's stock valued at $14,359,000 after acquiring an additional 34,115 shares during the last quarter. Connective Capital Management LLC bought a new position in Aspen Aerogels in the fourth quarter valued at approximately $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Aspen Aerogels by 47.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company's stock worth $6,990,000 after buying an additional 188,861 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new stake in shares of Aspen Aerogels in the fourth quarter worth $3,089,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.